Home / Auditor changes / Insight Molecular Diagnostics Inc.
Filed 2025-04-17 路 Form 8-K 路 Accession 0001641172-25-005288 micro
Price before filing: $2.83 (2025-04-16 close, split/dividend-adjusted)
Market cap at flag: $90.9M (2025-04-17) 路 Latest: $110.6M (2026-10-16)
| Window | IMDX | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -1.1% | +13.2% | -14.2% | 2025-05-19 |
| 90 days | +0.0% | +19.1% | -19.1% | 2025-07-16 |
| 180 days | +44.2% | +26.7% | +17.5% | 2025-10-14 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"On April 11, 2025, the Company terminated its relationship with Marcum as the Company's independent registered public accounting firm and, with the approval of the Audit Committee of the Company's Board of Directors, engaged CBIZ CPAs on April 16, 2025 as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: changed
Disagreements reported: no
Former auditor: Marcum LLP · New auditor: CBIZ CPAs P.C.
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.